Showing results (2171-2180 of 3,033) with videos related to

Sort By:
Pageof 304
British Journal of Cancer|April 3, 1999
Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancerS Hohaus, L Funk, S Martin, et al.
European Journal of Endocrinology|August 2, 2020
Influence of growth hormone therapy on the occurrence of a second neoplasm in survivors of childhood cancerCécile Thomas-Teinturier, Isabelle Oliver-Petit, Helene Pacquement, et al.
Experimental Hematology|March 30, 2006
Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myelomaMichael Hundemer, Stefanie Schmidt, Maud Condomines, et al.
Cell Reports Methods|December 1, 2022
A high-throughput electron tomography workflow reveals over-elongated centrioles in relapsed/refractory multiple myelomaTobias Dittrich, Sebastian Köhrer, Martin Schorb, et al.
British Journal of Haematology|May 24, 2022
Whole-body magnetic resonance imaging plus serological follow-up for early identification of progression in smouldering myeloma patients to prevent development of end-organ damageMarkus Wennmann, Hartmut Goldschmidt, Jennifer Mosebach, et al.
Journal of Medical Primatology|February 11, 2017
Spontaneous telangiectatic osteosarcoma in a rhesus macaque (Macaca mulatta)B Goldschmidt, M I Z Calado, F C Resende, et al.
Blood|June 19, 2012
Clinical and prognostic role of annexin A2 in multiple myelomaAnja Seckinger, Tobias Meissner, Jérôme Moreaux, et al.
Developmental Medicine and Child Neurology|August 21, 2025
Parental counselling and autopsy results: A retrospective diagnostic cohort study at a multidisciplinary fetal neurology clinicAvi Shariv, Michal Gafner, Zvi Leibovitz, et al.
The International Journal of Eating Disorders|December 18, 2024
Momentary Associations Across Specific Affective States and Dysregulated Eating Experiences Among Children and Adolescents With Loss of Control Eating SymptomsCaroline Christian, Victoria Bell, J Graham Thomas, et al.
Annals of Hematology|June 19, 2023
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma-a real-world multicenter retrospective cohort studyTamar Berger, Tzippy Shochat, Shlomzion Aumann, et al.
Pageof 304